FREE LEGAL CONSULT Avandia and Heart Attack
Avandia Diabetes
Avandia diabetes drug was approved primarily as a safer alternative for diabetes patients following the recall of Rezulin. The FDA never found Avandia diabetes drug to be safe, rather it appeared to pose a lesser risk of liver damage than Rezulin had. Despite Avandia diabetes drug approval, the FDA still maintained the agency would continue watching for signs of serious complications with diabetes patients using it.
Public Citizen consumer group pushed to have Rezulin removed from the market long before the actual recall and never found Avandia diabetes drug to be a safe alternative for patients. The FDA sent Avandia manufacturer a warning letter after finding the company was violating regulations. The Avandia manufacturers were promoting Avandia while minimizing the serious risks associated to the diabetes drug. The FDA had already objected to Avandia promotional materials, however, the Avandia manufacturer had still failed to discontinue misleading Avandia promotions.
If you would like more information, please contact an Avandia Lawyer.
September 8, 2003
In 2000, Rezulin diabetes drug was recalled after being linked to dozens of fatal liver disease instances. The FDA announced at the time of Rezulin recall that Acts and Avandia were safer alternative in "this important class of diabetes drug," which Rezulin was the first FDA approved drug of the newest class. Public Citizen consumer group criticized the FDA for waiting too long to issue the Rezulin recall and remained skeptical that other drugs, such as Avandia, would not also cause problems.
Now, a new study published in the September 9 issue of the Mayo Clinic Proceedings has reported that congestive heart failure can occur in Avandia patients. Already known to cause fluid accumulation, Avandia is now being discouraged from use amongst anyone with a history of congestive heart failure or chronic renal insufficiency until further Avandia studies have been performed.
Contact us to learn more